Table 2 Correlation between intensity of AXL expression in PTC tissues and clinicopathological characteristics
Variable | Strong positive | Weak positive | Negative | p-value |
|---|---|---|---|---|
Frequency (no. of patients) | 13 | 18 | 9 | |
Mean age (years) | 40.31 ± 13.76 | 44.72 ± 10.87 | 39.78 ± 14.15 | 0.332 |
Sex | 0.305 | |||
M | 1 (7.7) | 5 (27.8) | 1 (11.1) | |
F | 12 (92.3) | 13 (72.2) | 8 (88.9) | |
Microcarcinoma | 0.157 | |||
Yes | 5 (38.5) | 13 (72.2) | 6 (66.7) | |
No | 8 (61.5) | 5 (27.8) | 3 (33.3) | |
Extrathyroidal extension | 0.292 | |||
Yes | 12 (92.3) | 13 (72.2) | 6 (66.7) | |
No | 1 (7.7) | 5 (27.8) | 3 (33.3) | |
Tumour size | 0.535 | |||
T1 | 1 (7.7) | 4 (22.2) | 2 (22.2) | |
T2 | 0 (0) | 0 (0) | 0 (0) | |
T3 | 12 (92.3) | 14 (77.8) | 7 (77.8) | |
T4 | 0 (0) | 0 (0) | 0 (0) | |
Lymph node involvement | 0.253 | |||
N0 | 3 (23.1) | 7 (38.9) | 1 (11.1) | |
N1a | 9 (69.2) | 8 (44.4) | 5 (55.6) | |
N1b | 1 (7.7) | 3 (16.7) | 3 (33.3) | |
Distant metastasis | ||||
M0 | 0 | 0 | 0 | |
M1 | 0 | 0 | 0 | |
AJCC stage | 0.735 | |||
I | 8 (61.5) | 8 (44.4) | 5 (55.6) | |
II | 0 (0) | 0 (0) | 0 (0) | |
III | 4 (30.8) | 9 (50.0) | 3 (33.3) | |
IV | 1 (7.7) | 1 (5.6) | 1 (11.1) | |